Sort
82,697 grants matching “vaccine development”
Vaccine Induced Immunity in the Young and Aged
$2,410,029Rafi Ahmed · Emory University · U19 · FY2020 · AI
The humoral response to Zika virus infection and vaccination
$2,409,226Theodore Pierson · National Institute Of Allergy And Infectious Diseases · ZIA · FY2020 · AI
Safety/Tolerability/Immunogenicity of first-in-human Aβ DNA vaccine, AV-1959D Phase 1 trials in early-stage AD subjects: based on IND18953 cleared by FDA.
$2,408,617Michael G Agadjanyan · Institute For Molecular Medicine · R01 · FY2023 · AG
Immunological responses to pan-CoV vaccines
$2,408,043Yoshihiro Kawaoka · University Of Wisconsin-Madison · P01 · FY2021 · AI
The UCSD CD4 Collaborative Clinical Trial Unit
$2,407,704Constance Ann Benson · University Of California, San Diego · UM1 · FY2016 · AI
Multi-component HIV Vaccines Using Engineered Envelopes
$2,407,540Novartis Vaccines And Diagnostics, Inc. · P01 · FY2004 · AI
Core C: Biosecurity Core
$2,407,283James W. Leduc · University Of Texas Med Br Galveston · UC7 · FY2025 · AI
University of Puerto Rico Clinical Trials Unit
$2,406,550Carmen D Zorrilla · University Of Puerto Rico Med Sciences · U01 · FY2010 · AI
Specific and Broadly Active Monoclonal Antibody Therapeutics Against The Filoviruses
$2,406,479Erica Ollmann Saphire · La Jolla Institute For Immunology · U19 · FY2020 · AI
Harnessing human dendritic cell subsets for the design of novel immunotherapies
$2,406,478Juliana Idoyaga · Stanford University · DP2 · FY2015 · AR
Case AIDS Clinical Trials Unit
$2,405,283Michael Marcel Lederman · Case Western Reserve University · U01 · FY2007 · AI
System Biological Analyses of Innate and Adaptive Responses to Vaccination
$2,404,885Bali Pulendran · Emory University · U19 · FY2020 · AI
PHRU-Setshaba Clinical Trials Unit
$2,404,119Glenda E Gray · Wits Health Consortium (Pty), Ltd · UM1 · FY2023 · AI
CURE CTU
$2,404,040Stephen A Spector · University Of California, San Diego · UM1 · FY2025 · AI
Knockdown of Gene Expression in Immune Cells in Humanized Mice
$2,404,025Judy Lieberman · Immune Disease Institute, Inc. · RC4 · FY2010 · AI
Emory- Duke- Orlando- CDC (EmDOC) Clinical Trials Unit
$2,403,962Jeffrey Lennox · Emory University · UM1 · FY2017 · AI
Vaccine and Phylogeny Studies Of Simian Immunodeficiency Virus (SIV)
$2,403,879Vanessa M. Hirsch · National Institute Of Allergy And Infectious Diseases · Z01 · FY2008 · AI
Dana-Farber/Harvard Cancer Center Ovarian Cancer SPORE
$2,403,292Brigham And Women'S Hospital · P50 · FY2005 · CA
Microbiome Discovery and Mechanisms to Combat Antibiotic Resistance at Mucosal Surfaces
$2,402,665Robert A Britton · Baylor College Of Medicine · U19 · FY2022 · AI
Aging and Immunity to Infections
$2,402,413Laura Haynes · Trudeau Institute, Inc. · P01 · FY2009 · AG
An OpenData Portal to share SARS-CoV-2 drug repurposing data in real time
$2,402,379Matthew Hall · National Center For Advancing Translational Sciences · ZIA · FY2023 · TR
Innovative Influenza Therapeutic and Prophylactic for Biodefense Applications
$2,401,735Jane Ryan · Biota Scientific Management · U01 · FY2006 · AI
CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND RESPONSE
$2,400,000Andrew Pekosz · Johns Hopkins University · N01 · FY2021 · AI
UAB-MISS MACS/WIHS Combined Cohort Study
$2,400,000Mirjam-Colette Kempf · University Of Alabama At Birmingham · U01 · FY2019 · HL
Discovery of Chemical Probes and Therapeutic Leads, Phase II
$2,399,995Joseph M Fox · University Of Delaware · P20 · FY2024 · GM